Search

everythinglearnresearchcommunity

for

Search:↓

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Increased PPARGC1α relates to hair thinning in common baldness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

Low zinc and selenium levels in sheep are linked to hair loss and thyroid problems.

Hypothyroidism harms rat skin, but topical triiodothyronine may help improve it.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Aging skin is affected by inflammation, reduced stem cell function, and slower wound healing.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Stress can worsen skin conditions and stop hair growth by affecting the body's stress response system.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

High mTORC1 activity slows hair growth and causes it to lose color.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The free androgen index varies among women with different types of PCOS.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Autophagy prevents early aging and maintains lipid and pheromone balance in mouse glands.

Chinese women with PCOS have higher androgen levels, which change with age and weight.